Prospective randomised controlled trial of adults with perianal fistulising Crohn’s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol

INTRODUCTION: Perianal fistulising Crohn’s disease (pfCD) can be somewhat treatment refractory. Higher infliximab trough levels (TLIs) may improve fistula healing rates; however, it remains unclear whether escalating infliximab therapy to meet higher TLI targets using proactive, or routine, therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Bonita, De Gregorio, Michael, Pipicella, Joseph Louis, Vande Casteele, Niels, Andrews, Jane M, Begun, Jakob, Connell, William, D’Souza, Basil, Gholamrezaei, Ali, Hart, Ailsa, Liew, Danny, Radford-Smith, Graham, Rimola, Jordi, Sutherland, Tom, Toong, Catherine, Woods, Rodney, Wu, Yang, Xuan, Wei, Williams, Astrid-Jane, Ng, Watson, Ding, Nik Sheng, Connor, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252869/
https://www.ncbi.nlm.nih.gov/pubmed/34210720
http://dx.doi.org/10.1136/bmjopen-2020-043921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252869/
https://www.ncbi.nlm.nih.gov/pubmed/34210720
http://dx.doi.org/10.1136/bmjopen-2020-043921

Ejemplares similares